“Committed to Excellence in Life Sciences Executive Search”
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Biotechnology, Devices & Diagnostics, Life Sciences, Pharmaceutical
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…